Relapsed and Refractory
Hepatoblastoma (rrHBL)
Registry and Repository: A Liver Tumors Research Consortium (LTRC)
Initiative

Will

The Relapsed and Refractory Hepatoblastoma (rrHBL) Registry is one of the core initiatives of the Liver Tumors Research Consortium (LTRC), which is a collaboration among physicians and other care providers, scientists, and additional stakeholders (patients, parents), dedicated to gathering data and biological samples from children, adolescents, and young adults with liver tumors. The aim of this Registry is to gain a better understanding of rrHBL and relapsed and refractory hepatocellular neoplasm – not otherwise specified (rrHCN-NOS) and develop better treatment options and outcomes for patients everywhere.